About the Company
We do not have any company description for Enveric Biosciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ENVB News
ENVB Enveric Biosciences, Inc.
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead program is ...
Enveric Biosciences, Inc. (ENVB) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest market close, Enveric Biosciences, Inc. (ENVB) reached $0.93, with a -0.46% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.91%.
Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors
The most recent trading session ended with Enveric Biosciences, Inc. (ENVB) standing at $0.90, reflecting a -0.56% shift from the previouse trading day's closing. The stock trailed the S&P 500, which ...
Enveric Biosciences, Inc.
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely ...
Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors
The most recent trading session ended with Enveric Biosciences, Inc. (ENVB) standing at $0.90, reflecting a -0.56% shift from the previouse trading day's closing. The stock trailed the S&P 500 ...
Enveric Biosciences Inc (ENVB)
CAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ: ENVB), a biotechnology firm focusing on therapies for mental health disorders, has signed two non-binding term sheets with an ...
Enveric Biosciences Inc ENVB
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...